Maintenance immunotherapy is associated with a lower annualized relapse risk in double-negative neuromyelitis optica spectrum disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results